Featured Articles

  1. Holistic Implementation Of DCT Elements Drives Modern Research 2/2/2023

    Unearth the benefits of a DCT approach, such as additional flexibility that expands patient choices and extends a human touch into patient homes by replicating services normally performed on-site.

  2. Complex DCT Delivery: What Is Possible Outside Of A Site? 1/18/2023

    Todd McGrath, Chief Operating Officer, and Emily McDougal, Executive Director of Nurse Management, show how the decentralized delivery of complex clinical visits can benefit studies, sites, and patients.

  3. Home Support For DCTs: It's Not Just Patient-Centric, It's Good Business 11/10/2022

    Explore why patient- and family-centric trial designs are vital to promoting recruitment, retention, and quality care among challenging patient groups.

  4. How Level Of Touch Guides DCT Tools And Methods 10/24/2022

    To run clinical trials quickly, safely, and with high data integrity, it's effective to assess trials by degree of touch. Discover how different trial types are suited to the application of different tools and methods.

  5. Balancing Clinical Care With Digital Utility In Hybrid Trials 10/24/2022

    To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.

  6. What Does “Good” Look Like In A Decentralized Clinical Trial? 8/23/2022

    Delve into the answer to the question: What is the right way to perform decentralized trials in order that it can be controlled and managed effectively?

  7. The Catalyst Of Decentralized Clinical Trials: Combining Clinical And Digital 7/27/2022

    Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. This webinar shares important factors to consider to build your DCT ‘molecule’ successfully.

  8. Tau Pathology Clinical Trial 4/28/2022

    Working in close collaboration with the manufacturer of a novel treatment for Progressive Supranuclear Palsy, MRN played a major role in delivering Home Trial Support (HTS) for 79 patients in several different countries.

  9. Early Onset Alzheimer's Trial 3/24/2022

    Washington University conducted several trials of a rare, inherited form of Alzheimer's that typically develops in a person's 50s, 40s or even 30s. Find out how they were able to be assisted in this case study.

  10. Where Patient-Centricity Meets Financial Return For DCT Solutions 3/24/2022

    With ~10% of clinical trials started between 2014 and 2022 incorporating DCT elements, why is the adoption of something that appears so beneficial not more widely embraced?